

Senate
Study
Bill
3136
-
Introduced


SENATE
FILE
_____


BY
(PROPOSED
COMMITTEE


ON
JUDICIARY
BILL
BY


CHAIRPERSON
ZAUN)


A
BILL
FOR


An
Act
relating
to
the
medical
cannabidiol
Act,
and
including
1


transition
provisions.
2


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3


TLSB
5644XC
(9)
88


ss/rh



S.F.
_____


Section
1.
Section
124E.2,
subsection
2,
paragraph
i,
Code
1


2020,
is
amended
to
read
as
follows:
2


i.
Untreatable


Severe
or
chronic
pain.
3


Sec.
2.
Section
124E.2,
subsection
2,
Code
2020,
is
amended
4


by
adding
the
following
new
paragraphs:
5


NEW
PARAGRAPH
.
j.
Autism.
6


NEW
PARAGRAPH
.
k.
Post-traumatic
stress
disorder.
7


Sec.
3.
Section
124E.2,
subsections
5
and
6,
Code
2020,
are
8


amended
to
read
as
follows:
9


5.
“Health
care
practitioner”
means
an
individual
licensed
10


under
chapter
148
to
practice
medicine
and
surgery
or
11


osteopathic
medicine
and
surgery
,
a
physician
assistant


12


licensed
under
chapter
148C,
a
podiatrist
licensed
under
13


chapter
149,
an
advanced
registered
nurse
practitioner
licensed


14


under
chapter
152,
or
an
advanced
practice
registered
nurse
15


licensed
under
chapter
152E,
who
is
a
patient’s
primary
care
16


provider.
“Health
care
practitioner”
shall
not
include
a
17


physician
assistant
licensed
under


chapter
148C
or
an
advanced
18


registered
nurse
practitioner
licensed
pursuant
to


chapter
152
19


or
152E
.
20


6.
“Medical
cannabidiol”
means
any
pharmaceutical
21


grade
cannabinoid
found
in
the
plant
Cannabis
sativa
L.
or
22


Cannabis
indica
or
any
other
preparation
thereof
that
has


23


a
tetrahydrocannabinol
level
of
no
more
than
three
percent
24


and
that
is
delivered
in
a
form
recommended
by
the
medical
25


cannabidiol
board
,
approved
by
the
board
of
medicine,
and
26


adopted
by
the
department
pursuant
to
rule.
27


Sec.
4.
Section
124E.2,
subsection
8,
Code
2020,
is
amended


28


by
striking
the
subsection.
29


Sec.
5.
NEW
SECTION


.
124E.3A
Health
care
practitioner
30


decertification.


31


1.
The
department
shall
adopt
rules
to
allow
a
health
32


care
practitioner
who
has
issued
a
written
certification
to
a
33


patient
to
revoke
the
certification.
34


2.
A
medical
cannabidiol
registration
card
issued
to
35


-1-


LSB
5644XC
(9)
88


ss/rh
1/
13



























S.F.
_____


a
patient
or
primary
caregiver
on
the
basis
of
a
written
1


certification
that
has
been
revoked
pursuant
to
subsection
1
2


shall
not
be
valid
after
the
date
of
revocation.
3


3.
A
patient
or
primary
caregiver
in
possession
of
medical
4


cannabidiol
after
the
revocation
of
a
written
certification
5


shall
not
be
subject
to
a
penalty
under
section
124E.16
for
6


thirty
days
after
the
revocation.
Before
the
expiration
of
7


thirty
days
after
revocation,
the
patient
or
primary
caregiver
8


shall
return
any
unused
medical
cannabidiol
to
a
medical
9


cannabidiol
dispensary
unless
the
patient
has
been
recertified
10


pursuant
to
subsection
4.
11


4.
A
patient
whose
written
certification
has
been
12


revoked
pursuant
to
subsection
1
may
receive
a
new
written
13


certification
pursuant
to
section
124E.3.
If
a
patient
14


receives
a
new
written
certification
within
thirty
days
of
15


the
revocation
of
the
initial
certification,
the
patient
16


or
the
patient’s
primary
caregiver
may
retain
any
medical
17


cannabidiol
still
in
the
possession
of
the
patient
or
the
18


primary
caregiver.
A
patient
shall
not
receive
more
than
two
19


written
certifications
per
year.
20


Sec.
6.
Section
124E.4,
subsections
1
and
5,
Code
2020,
are
21


amended
to
read
as
follows:
22


1.
Issuance
to
patient.
23


a.


Subject
Except
as
otherwise
provided
in
paragraph
“b”
,
24


and
subject
to
subsection
7
,
the
department
may
approve
the
25


issuance
of
issue
a
medical
cannabidiol
registration
card
by
26


the
department
of
transportation
to
a
patient
who:
27


a.
(1)
Is
at
least
eighteen
years
of
age.
28


b.
(2)
Is
a
permanent
resident
of
this
state.
29


c.


(3)
Submits
a
written
certification
to
the
department
30


signed
by
the
patient’s
health
care
practitioner
that
the
31


patient
is
suffering
from
a
debilitating
medical
condition.
32


d.


(4)
Submits
an
application
to
the
department,
on
a
form
33


created
by
the
department,
in
consultation
with
the
department


34


of
transportation,
that
contains
all
of
the
following:
35


-2-


LSB
5644XC
(9)
88


ss/rh
2/
13
























S.F.
_____


(1)
(a)
The
patient’s
full
name,
Iowa
residence
address,
1


date
of
birth,
and
telephone
number.
2


(2)


(b)
A
copy
of
the
patient’s
valid
photo
identification.
3


(3)
(c)
Full
name,
address,
and
telephone
number
of
the
4


patient’s
health
care
practitioner.
5


(4)
(d)
Full
name,
residence
address,
date
of
birth,
and
6


telephone
number
of
each
primary
caregiver
of
the
patient,
if
7


any.
8


(5)


(e)
Any
other
information
required
by
rule.
9


e.
(5)
Submits
a
medical
cannabidiol
registration
card
10


fee
of
one
hundred
dollars
to
the
department.
If
the
patient
11


attests
to
receiving
social
security
disability
benefits,
12


supplemental
security
insurance
payments,
or
being
enrolled
in
13


the
medical
assistance
program,
the
fee
shall
be
twenty-five
14


dollars.
15


f.


Has
not
been
convicted
of
a
disqualifying
felony
offense.
16


b.
Subject
to
subsection
7,
the
department
may
issue
a
17


medical
cannabidiol
registration
card
to
a
patient
who
provides


18


documentation
to
the
department,
on
a
form
prescribed
by
the


19


department,
that
the
patient
is
receiving
hospice
care
in
this
20


state.


21


5.
Expiration
date
of
card.
A
medical
cannabidiol
22


registration
card
issued
pursuant
to
this
section
shall
expire
23


one
year


two
years
after
the
date
of
issuance
and
may
be
24


renewed.
25


Sec.
7.
Section
124E.4,
subsection
2,
unnumbered
paragraph
26


1,
Code
2020,
is
amended
to
read
as
follows:


27


A
medical
cannabidiol
registration
card
issued
to
a
patient
28


by
the
department
of
transportation


pursuant
to
subsection
1
29


shall
contain,
at
a
minimum,
all
of
the
following:
30


Sec.
8.
Section
124E.4,
subsection
3,
unnumbered
paragraph
31


1,
Code
2020,
is
amended
to
read
as
follows:
32


For
a
patient
in
a
primary
caregiver’s
care,
subject
to
33


subsection
7
,
the
department
may
approve
the
issuance
of


issue
34


a
medical
cannabidiol
registration
card
by
the
department
of
35


-3-


LSB
5644XC
(9)
88


ss/rh
3/
13































S.F.
_____


transportation
to
the
primary
caregiver
who:
1


Sec.
9.
Section
124E.4,
subsection
3,
paragraph
b,
2


unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as
3


follows:
4


Submits
an
application
to
the
department,
on
a
form
created
5


by
the
department,
in
consultation
with
the
department
of


6


transportation,
that
contains
all
of
the
following:
7


Sec.
10.
Section
124E.4,
subsection
3,
paragraph
c,
Code
8


2020,
is
amended
by
striking
the
paragraph.
9


Sec.
11.
Section
124E.4,
Code
2020,
is
amended
by
adding
the
10


following
new
subsection:
11


NEW
SUBSECTION


.
3A.
Issuance
to
an
institution.
The
12


department
shall
adopt
rules
for
the
issuance
of
a
caregiver
13


registration
card
to
an
institution,
including
but
not
limited
14


to
a
school,
university,
nursing
home,
long-term
care
facility,
15


correctional
facility,
or
jail,
allowing
employees
of
the
16


institution
to
administer
medical
cannabidiol
to
patients
in
17


the
care
of
the
institution.
18


Sec.
12.
Section
124E.4,
subsection
4,
unnumbered
paragraph
19


1,
Code
2020,
is
amended
to
read
as
follows:
20


A
medical
cannabidiol
registration
card
issued
by
the
21


department
of
transportation


to
a
primary
caregiver
pursuant
to
22


subsection
3
shall
contain,
at
a
minimum,
all
of
the
following:
23


Sec.
13.
Section
124E.4,
subsection
6,
Code
2020,
is
amended
24


by
striking
the
subsection.
25


Sec.
14.
Section
124E.5,
subsection
2,
Code
2020,
is
amended
26


to
read
as
follows:


27


2.
The
medical
cannabidiol
board
shall
convene
at
least
28


twice
but
no
more
than
four
times
per
year.
29


Sec.
15.
Section
124E.5,
subsection
3,
paragraph
b,
Code
30


2020,
is
amended
to
read
as
follows:


31


b.
Making
recommendations
relating
to
the
removal
or
32


addition
of
debilitating
medical
conditions
to
the
list
of
33


allowable
debilitating
medical
conditions
for
which
the
medical
34


use
of
cannabidiol
under
this
chapter
would
be
medically
35


-4-


LSB
5644XC
(9)
88


ss/rh
4/
13









S.F.
_____


beneficial.
The
department
shall
adopt
rules
to
modify
the
1


list
of
allowable
debilitating
medical
conditions
consistent


2


with
recommendations
of
the
board.
3


Sec.
16.
Section
124E.5,
subsection
4,
Code
2020,
is
amended
4


to
read
as
follows:
5


4.
Recommendations
made
by
the
medical
cannabidiol
board
6


pursuant
to
subsection
3
,
paragraphs
“b”
and
“e”
,
shall
be
made
7


to
the
board
of
medicine
department
for
consideration,
and
if
8


approved,
shall
be
adopted
by
the
board
of
medicine


department
9


by
rule.
10


Sec.
17.
Section
124E.6,
subsection
4,
Code
2020,
is
amended
11


to
read
as
follows:
12


4.
The
department
shall
require
each
medical
cannabidiol
13


manufacturer
to
contract
with
the
state
hygienic
laboratory
at
14


the
university
of
Iowa
in
Iowa
City
or
an
independent
medical
15


cannabidiol
testing
laboratory
to
perform
spot-check
testing
16


of
the
medical
cannabidiol
produced
by
the
manufacturer
as
17


provided
in
section
124E.7
.
The
department
shall
require
that
18


the
laboratory
report
testing
results
to
the
manufacturer
19


and
the
department


in
a
manner
determined
by
the
department
20


pursuant
to
rule.
21


Sec.
18.
Section
124E.6,
Code
2020,
is
amended
by
adding
the
22


following
new
subsection:
23


NEW
SUBSECTION


.
6.
A
medical
cannabidiol
manufacturer
24


shall
pay
a
renewal
fee
of
two
thousand
dollars
per
year
to
the
25


department
to
renew
a
medical
cannabidiol
manufacturer
license
26


in
addition
to
any
other
requirement
imposed
by
the
department
27


by
rule.
28


Sec.
19.
Section
124E.7,
subsection
1,
Code
2020,
is
amended


29


to
read
as
follows:
30


1.
A
medical
cannabidiol
manufacturer
shall
contract
with


31


the
state
hygienic
laboratory
at
the
university
of
Iowa
in
Iowa
32


City
or
an
independent
medical
cannabidiol
testing
laboratory
33


to
perform
spot-check
testing
of
the
medical
cannabidiol
34


manufactured
by
the
medical
cannabidiol
manufacturer
as
to
35


-5-


LSB
5644XC
(9)
88


ss/rh
5/
13












S.F.
_____


content,
contamination,
and
consistency.
The
cost
of
all
1


laboratory
testing
shall
be
paid
by
the
medical
cannabidiol
2


manufacturer.
The
state
hygienic
laboratory
shall
not
charge


3


a
medical
cannabidiol
manufacturer
more
than
fifty
thousand
4


dollars
per
year
to
perform
spot-check
testing.


5


Sec.
20.
NEW
SECTION


.
124E.7A
Medical
cannabidiol
testing
6


laboratory
——
review
committee.
7


1.
The
department
shall
establish
a
committee
to
review
8


product
matrices,
testing
protocols,
and
testing
procedures
9


used
by
the
state
hygienic
laboratory
at
the
university
of
Iowa
10


in
Iowa
City
and
any
independent
medical
cannabidiol
testing
11


laboratory
operating
in
this
state
not
later
than
September
1.
12


2.
a.
The
committee
shall
consist
of
the
following
members,
13


selected
by
the
department:
14


(1)
Three
members
representing
independent
medical
15


cannabidiol
testing
laboratories.
16


(2)
Two
members
who
shall
be
professors
at
regents
17


institutions
with
relevant
education
and
experience,
as
18


determined
by
rule
of
the
department,
who
are
not
associated
19


with
the
state
hygienic
laboratory
at
the
university
of
Iowa
20


in
Iowa
City
or
any
independent
medical
cannabidiol
testing
21


laboratory.
22


b.
Members
shall
serve
for
a
period
of
time
as
determined
by
23


rules
of
the
department.
24


3.
Prior
to
implementing
any
new
product
matrix,
testing
25


protocol,
or
testing
procedure,
the
state
hygienic
laboratory
26


at
the
university
of
Iowa
in
Iowa
City
and
any
independent
27


medical
cannabidiol
testing
laboratory
operating
in
this
28


state
shall
submit
the
new
product
matrix,
testing
protocol,
29


or
testing
procedure
to
the
committee.
The
committee
shall
30


approve
or
disapprove
of
the
product
matrix,
testing
protocol,
31


or
testing
procedure
by
a
simple
majority
vote.
The
state
32


hygienic
laboratory
at
the
university
of
Iowa
in
Iowa
City
33


and
any
independent
medical
cannabidiol
testing
laboratory
34


operating
in
this
state
shall
not
use
a
new
product
matrix,
35


-6-


LSB
5644XC
(9)
88


ss/rh
6/
13







S.F.
_____


testing
protocol,
or
testing
procedure
until
it
has
been
1


approved
by
the
committee,
and
shall
not
use
a
new
product
2


matrix,
testing
protocol,
or
testing
procedure
that
has
been
3


disapproved
by
the
committee.
Product
matrices,
testing
4


protocols,
and
testing
procedures
in
use
prior
to
July
1,
2020,
5


shall
not
be
subject
to
approval
by
the
committee
except
as
6


provided
in
subsection
4.
7


4.
A
medical
cannabidiol
manufacturer
of
a
product
that
has
8


failed
a
test
administered
by
the
state
hygienic
laboratory
9


at
the
university
of
Iowa
in
Iowa
City
or
an
independent
10


medical
cannabidiol
testing
laboratory
operating
in
this
state
11


may
dispute
the
result
and
request
that
the
committee
review
12


a
product
matrix,
testing
protocol,
or
testing
procedure
13


used
in
testing
the
product.
The
committee
shall
approve
or
14


disapprove
of
the
result,
and
in
the
case
of
disapproval,
shall
15


explain
the
reason
for
disapproval.
A
medical
cannabidiol
16


manufacturer
of
a
product
tested
using
a
product
matrix,
17


testing
protocol,
or
testing
procedure
disapproved
of
by
the
18


committee
may
request
that
the
product
be
tested
again
without
19


the
disapproved
product
matrix,
testing
protocol,
or
testing
20


procedure.
21


5.
The
department
shall
adopt
rules
to
administer
this
22


section.
23


Sec.
21.
Section
124E.8,
Code
2020,
is
amended
by
adding
the
24


following
new
subsection:
25


NEW
SUBSECTION


.
5.
A
medical
cannabidiol
dispensary
shall
26


pay
an
annual
renewal
fee
of
two
thousand
dollars
to
the
27


department
to
renew
a
medical
cannabidiol
dispensary
license
28


in
addition
to
any
other
requirement
imposed
by
the
department
29


by
rule.
30


Sec.
22.
Section
124E.9,
Code
2020,
is
amended
by
adding
the
31


following
new
subsections:
32


NEW
SUBSECTION


.
13.
A
medical
cannabidiol
dispensary
33


may
employ
a
pharmacist
or
pharmacy
technician
licensed
or
34


registered
pursuant
to
chapter
155A.
35


-7-


LSB
5644XC
(9)
88


ss/rh
7/
13





S.F.
_____


NEW
SUBSECTION
.
14.
A
medical
cannabidiol
dispensary
shall
1


not
dispense
more
than
a
combined
total
of
twenty-five
grams
2


of
tetrahydrocannabinol
to
a
patient
and
the
patient’s
primary
3


caregiver
in
a
ninety-day
period.
4


Sec.
23.
Section
124E.11,
subsection
1,
paragraph
b,
5


subparagraph
(1),
subparagraph
divisions
(a)
and
(c),
Code
6


2020,
are
amended
to
read
as
follows:
7


(a)
To
authorized
employees
or
agents
of
the
department
and


8


the
department
of
transportation


as
necessary
to
perform
the
9


duties
of
the
department
and
the
department
of
transportation
10


pursuant
to
this
chapter
.
11


(c)
To
authorized
employees
of
a
medical
cannabidiol
12


dispensary,
but
only
for
the
purpose


purposes
of
verifying
13


that
a
person
is
lawfully
in
possession
of
a
medical
14


cannabidiol
registration
card
issued
pursuant
to
this
chapter
15


and
that
a
patient
or
primary
caregiver
has
not
purchased


16


tetrahydrocannabidiol
in
excess
of
the
amount
authorized
by
17


this
chapter


.
18


Sec.
24.
Section
124E.11,
subsection
1,
paragraph
b,
19


subparagraph
(1),
Code
2020,
is
amended
by
adding
the
following
20


new
subparagraph
division:
21


NEW
SUBPARAGRAPH
DIVISION


.
(e)
To
a
health
care
22


practitioner,
but
only
for
the
purpose
of
monitoring
the
23


amount
of
medical
cannabidiol
purchased
by
the
health
care
24


practitioner’s
patient
or
the
primary
caregiver
of
a
patient.
25


Sec.
25.
Section
124E.11,
subsection
2,
paragraph
c,
Code
26


2020,
is
amended
to
read
as
follows:


27


c.
Establish
the
form
and
quantity
of
medical
cannabidiol
28


allowed
to
be
dispensed
to
a
patient
or
primary
caregiver
29


pursuant
to
this
chapter
as
appropriate
to
serve
the
medical
30


needs
of
patients
with
debilitating
medical
conditions,
subject
31


to
recommendation
by
the
medical
cannabidiol
board
and
approval
32


by
the
board
of
medicine


department
.
33


Sec.
26.
Section
124E.12,
subsections
6
and
7,
Code
2020,
34


are
amended
to
read
as
follows:
35


-8-


LSB
5644XC
(9)
88


ss/rh
8/
13















S.F.
_____


6.
The
department
,
the
department
of
transportation,
1


and
any
health
care
practitioner,
including
any
authorized
2


agent
or
employee
thereof,
are
not
subject
to
any
civil
3


or
disciplinary
penalties
by
the
board
of
medicine
or
any
4


business,
occupational,
or
professional
licensing
board
or
5


entity,
solely
for
activities
conducted
relating
to
a
patient’s
6


possession
or
use
of
medical
cannabidiol
as
authorized
under
7


this
chapter
.
Nothing
in
this
section
affects
a
professional
8


licensing
board
from
taking
action
in
response
to
violations
of
9


any
other
section
of
law.
10


7.
Notwithstanding
any
law
to
the
contrary,
the
department,
11


the
department
of
transportation,


the
governor,
or
any
employee
12


of
any
state
agency
shall
not
be
held
civilly
or
criminally
13


liable
for
any
injury,
loss
of
property,
personal
injury,
or
14


death
caused
by
any
act
or
omission
while
acting
within
the
15


scope
of
office
or
employment
as
authorized
under
this
chapter
.
16


Sec.
27.
NEW
SECTION


.
124E.20
Observational
effectiveness
17


study.
18


The
department
shall,
upon
receipt
of
funding,
conduct
19


an
observational
effectiveness
study
in
cooperation
with
20


patients
and
health
care
practitioners
and
pursuant
to
rules
21


of
the
department
in
order
to
study
the
effectiveness
of
22


medical
cannabidiol
in
the
treatment
of
debilitating
medical
23


conditions.
24


Sec.
28.
PROTECTION
OF
FEDERAL
FUNDING.
The
department
25


of
public
health
shall
request
guarantees
from
the
agencies
26


of
the
federal
government
providing
funding
to
educational
27


and
long-term
care
facilities
that
facilities
with
policies
28


allowing
patients
to
possess
medical
cannabidiol
on
the
grounds
29


of
the
facilities
consistent
with
chapter
124E
or
allowing
30


facility
staff
to
administer
medical
cannabidiol
to
a
patient
31


shall
not
lose
eligibility
for
any
federal
funding
due
to
such
32


policies.
33


Sec.
29.
TRANSITION
PROVISIONS.
A
medical
cannabidiol
34


registration
card
issued
by
the
department
of
transportation
35


-9-


LSB
5644XC
(9)
88


ss/rh
9/
13






S.F.
_____


prior
to
July
1,
2020,
remains
effective
and
continues
in
1


effect
as
issued
for
the
twelve-month
period
following
its
2


issuance.
3


EXPLANATION
4


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
5


the
explanation’s
substance
by
the
members
of
the
general
assembly.
6


This
bill
relates
to
the
medical
cannabidiol
Act.
7


The
bill
adds
autism
and
post-traumatic
stress
disorder
8


to
the
list
of
debilitating
medical
conditions
for
which
a
9


written
certification
for
a
medical
cannabidiol
registration
10


card
may
be
issued.
The
bill
replaces
“untreatable
pain”
with
11


“severe
or
chronic
pain”
on
the
list
of
debilitating
medical
12


conditions.
The
bill
adds
licensed
physician
assistants,
13


podiatrists,
advanced
registered
nurse
practitioners,
and
14


advanced
practice
registered
nurses
to
the
list
of
health
care
15


practitioners
that
may
issue
written
certifications
for
a
16


medical
cannabidiol
registration
card.
17


The
bill
removes
the
3
percent
tetrahydrocannabinol
(THC)
18


limit
from
the
definition
of
medical
cannabidiol.
The
bill
19


instead
prohibits
a
patient
or
a
primary
caregiver
from
20


purchasing
more
than
25
grams
of
THC
in
a
90-day
period.
The
21


bill
allows
medical
cannabidiol
dispensaries
to
access
the
22


registry
of
medical
cannabidiol
patients
to
verify
that
a
23


patient
or
primary
caregiver
has
not
purchased
more
than
25
24


grams
of
THC
in
a
90-day
period.
The
bill
also
allows
a
health
25


care
practitioner
to
access
the
registry
of
medical
cannabidiol
26


patients
in
order
to
monitor
the
amount
of
medical
cannabidiol
27


purchased
by
the
health
care
practitioners’s
patient
or
the
28


primary
caregiver
of
a
patient.
29


The
bill
removes
the
board
of
medicine
from
the
process
30


of
amending
the
acceptable
form
and
quantity
of
medical
31


cannabidiol.
32


The
bill
directs
the
department
of
public
health
to
adopt
33


rules
allowing
a
health
care
practitioner
who
has
issued
a
34


written
certification
for
a
medical
cannabidiol
registration
35


-10-


LSB
5644XC
(9)
88


ss/rh
10/
13



S.F.
_____


card
to
a
patient
to
revoke
that
certification.
A
medical
1


cannabidiol
registration
card
issued
on
the
basis
of
a
written
2


certification
shall
no
longer
be
valid.
A
patient
or
primary
3


caregiver
with
a
revoked
written
certification
has
30
days
4


to
dispose
of
medical
cannabidiol
still
in
the
possession
of
5


the
patient
or
primary
caregiver
or
to
receive
another
written
6


certification.
A
patient
or
primary
caregiver
shall
not
7


receive
more
than
two
written
certifications
per
year.
8


The
bill
removes
provisions
preventing
a
patient
or
a
9


primary
caregiver
from
receiving
a
medical
cannabidiol
10


registration
card
if
the
patient
or
primary
caregiver
has
been
11


convicted
of
a
disqualifying
felony.
12


The
bill
directs
the
department
of
public
health
to
13


adopt
rules
for
issuance
of
a
caregiver
medical
cannabidiol
14


registration
card
to
an
institution,
including
but
not
limited
15


to
a
school,
university,
nursing
home,
long-term
care
facility,
16


correctional
facility,
or
jail,
to
allow
employees
of
the
17


institution
to
administer
medical
cannabidiol
to
patients
18


in
the
care
of
the
institution.
The
bill
also
permits
the
19


department
of
public
health
to
issue
a
medical
cannabidiol
20


registration
card
to
a
patient
receiving
hospice
care
in
this
21


state
without
first
receiving
a
written
certification
from
a
22


health
care
practitioner.
23


The
bill
changes
the
expiration
date
of
medical
cannabidiol
24


registration
cards
from
one
year
after
the
date
of
issuance
to
25


two
years
after
the
date
of
issuance.
26


The
bill
removes
the
department
of
transportation
from
the
27


process
of
applying
for
and
receiving
a
medical
cannabidiol
28


registration
card
and
requires
the
department
of
public
health
29


to
issue
medical
cannabidiol
registration
cards
and
makes
30


conforming
Code
changes.
A
medical
cannabidiol
registration
31


card
previously
issued
by
the
department
of
transportation
32


prior
to
July
1,
2020,
remains
effective
and
continues
in
33


effect
for
the
12-month
period
following
its
issuance.
34


The
bill
allows
the
medical
cannabidiol
board
to
meet
more
35


-11-


LSB
5644XC
(9)
88


ss/rh
11/
13



S.F.
_____


than
four
times
per
year.
1


The
bill
requires
the
department
of
public
health
to
2


adopt
rules
to
modify
the
list
of
debilitating
medical
3


conditions
for
which
a
certification
for
a
medical
cannabidiol
4


registration
card
may
be
issued
when
the
medical
cannabidiol
5


board
recommends
such
a
change.
The
bill
removes
the
board
6


of
medicine
from
the
process
of
adding
debilitating
medical
7


conditions
to
the
list
of
debilitating
conditions
for
which
a
8


written
certification
for
a
medical
cannabidiol
registration
9


card
may
be
issued.
10


The
bill
makes
changes
with
respect
to
medical
cannabidiol
11


manufacturers,
medical
cannabidiol
dispensaries,
and
medical
12


cannabidiol
product
testing.
A
medical
cannabidiol
testing
13


laboratory
must
report
testing
results
to
the
department
of
14


public
health
in
addition
to
the
manufacturer
of
the
product
15


being
tested.
The
bill
provides
that
an
annual
renewal
fee
16


for
a
medical
cannabidiol
manufacturer
license
or
medical
17


cannabidiol
dispensary
license
shall
be
$2,000.
The
state
18


hygienic
laboratory
at
the
university
of
Iowa
in
Iowa
City
19


shall
not
charge
a
medical
cannabidiol
manufacturer
more
20


than
$50,000
per
year
for
the
testing
of
medical
cannabidiol
21


products.
22


The
bill
requires
the
department
of
public
health
to
23


establish
a
committee
to
review
product
matrices,
testing
24


protocols,
and
testing
procedures
used
by
medical
cannabidiol
25


testing
laboratories.
The
committee
shall
consist
of
five
26


members,
selected
by
the
department
of
public
health,
with
27


three
members
representing
independent
medical
cannabidiol
28


testing
laboratories
and
two
members
who
are
professors
at
29


regents
institutions
with
relevant
education
and
experience
and
30


no
association
with
any
medical
cannabidiol
testing
laboratory.
31


Prior
to
implementing
any
new
product
matrix,
testing
protocol,
32


or
testing
procedure,
a
medical
cannabidiol
testing
laboratory
33


must
submit
the
product
matrix,
protocol,
or
procedure
to
34


the
committee
for
approval.
A
medical
cannabidiol
testing
35


-12-


LSB
5644XC
(9)
88


ss/rh
12/
13



S.F.
_____


laboratory
shall
not
use
a
new
product
matrix,
protocol,
or
1


procedure
that
has
not
been
approved
by
the
committee
or
has
2


been
disapproved.
Product
matrices,
protocols,
and
procedures
3


in
use
prior
to
July
1,
2020,
are
not
subject
to
review,
4


except
that
a
medical
cannabidiol
manufacturer
of
a
product
5


that
has
failed
a
test
administered
by
a
medical
cannabidiol
6


testing
laboratory
may
contest
the
results
of
the
test
with
the
7


committee,
who
shall
approve
or
disapprove
the
results
of
the
8


test.
A
manufacturer
of
a
product
that
failed
a
test
that
was
9


disapproved
by
the
committee
may
request
that
the
product
be
10


tested
again
without
the
disapproved
product
matrix,
testing
11


protocol,
or
testing
procedure
by
the
committee.
12


The
bill
requires
the
department
of
public
health
to
conduct
13


a
study
on
the
efficacy
of
medical
cannabidiol
in
treating
14


patients
with
debilitating
medical
conditions
upon
receipt
15


of
funding.
The
bill
also
requires
the
department
of
public
16


health
to
request
guarantees
from
agencies
of
the
federal
17


government
providing
funding
to
educational
and
long-term
care
18


facilities
in
the
state
that
such
facilities
shall
not
lose
19


such
funding
for
allowing
patients
to
possess
and
use
medical
20


cannabidiol
on
the
grounds
of
the
facilities.
21


-13-


LSB
5644XC
(9)
88


ss/rh
13/
13

